The trial into the now-defunct blood testing startup Theranos has begun, with founder Elizabeth Holmes facing several charges of criminal fraud.
Prosecutors alleged Holmes “lied and cheated” for money and fame during the first day of one of the most closely watched trials of a U.S corporate executive in years.
The former Silicon Valley star is accused of deceiving investors and patients, by claiming Theranos technology could detect common illnesses using just a few drops of blood from a finger prick.
The company collapsed in 2015 after it emerged the blood-testing devices did not work, and had instead been operating commercially available machines made by other manufacturers.
“Significant problems brewing”
Prosecutors claimed that Holmes and other executives turned to fraud in 2009 after big pharmaceutical firms refused to back Theranos and the company faced bankruptcy.
Holmes lied about tests and exaggerated the company’s performance to secure millions of dollars of investments between 2010 to 2015.
This included false claims that the tests had been processed by pharmaceutical giant Pfizer, and that the technology was being used in the field by the U.S military.
Defence tells court Holmes is “no villain”
At the centre of Holmes’ defence is the argument she never intended to commit fraud.
Instead, they argue, Theranos is a high-profile example of a startup that simply did not work, much like thousands of other failed business ideas.
They told jurors that Holmes is not a villain, but rather a hard-working, young and naive businesswoman, who poured much of her life into the company.
“Failure is not a crime. Trying your hardest and coming up short is not a crime,” defence attorney Lance Wade said.
“In the end, Theranos failed and Ms Holmes walked away with nothing,” he told the jury.
Former executive and romantic partner also charged
Ex-Theranos executive Ramesh Balwani – who was romantically involved with Holmes for years, faces the same charges, but will be tried separately.
He has pleaded not guilty.
According to court documents released to the public, Holmes has accused Balwani of years of emotional and psychological abuse – allegations which Balwani denies.
Holmes’ lawyers have indicated she is highly likely to take the witness stand and testify about the effect her relationship with Balwani had on her mental state.
Court case the culmination of ill-fated saga
Holmes’ story is one which has peaked public interest.
After founding Theranos in 2003, aged 19, Holmes was fast-tracked for Silicon Valley success – she was at one point dubbed the world’s youngest self-made female billionaire and the “next Steve Jobs”.
Theranos “dazzled” large firms such as Walgreens and pharmacy companies into agreeing testing partnerships, as well as securing investments from high-profile figures like media mogul Rupert Murdoch and former U.S secretary of state Henry Kissinger.
Her story has become the subject of documentaries, podcasts and books. A TV miniseries and a film based on her life are in the works.
A tumultuous story will now culminate in a decision made in a California courtroom, with the case expected to last months.
AI infrastructure revolutionizes capital raising, with Nvidia, OpenAI, and Oracle leading; explore funding shifts and future impacts.
The AI infrastructure boom is transforming how companies raise capital, with Nvidia and OpenAI leading the charge. Explore the shifts in funding frameworks and what they mean for the future of AI investment.
Oracle is aiming to raise $45 to $50 billion, signalling confidence in the growing AI market. We break down how e
Equity issuance, bond deals, and circular financing are influencing long-term infrastructure development.
Despite rapid growth in AI usage, monetisation challenges remain beyond 2027.
Brad Gastwirth from Circular Technologies explains why financing won’t be a bottleneck and what traditional structures mean for the evolving AI landscape.
Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker
Australia’s inflation hits 3.8%, raising concerns for households; Dr. Enticott discusses implications for everyday Australians and economic planning.
Australia’s inflation has surged to 3.8%, sparking concern for households and businesses. Experts warn that rising prices could threaten financial stability if the government does not act in the upcoming budget.
Dr Steven Enticott from CIA Tax joins Ticker to break down what this inflation spike means for everyday Australians. He also explains why inflation above the Reserve Bank’s target band is particularly significant and how it affects economic planning.
Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker
U.S. stocks rose Monday, driven by Oracle gains, as investors overlooked recent silver and bitcoin losses ahead of earnings week.
U.S. equities climbed on Monday as Wall Street kicked off a new month of trading. Investors looked past recent losses in silver and bitcoin, with optimism returning to major indices. The S&P 500 rose 0.7%, led by gains in Oracle shares following the company’s announcement to raise up to £50 billion for cloud capacity.
The Dow Jones Industrial Average surged 501 points, while the Nasdaq Composite increased 0.9%. Analysts note that the broader market is showing resilience despite mixed signals from tech and commodities.
More than 100 S&P 500 companies are expected to report earnings this week. Strong growth is predicted, even as some high-profile sell-offs continue to make headlines.